Patents by Inventor Sunao Sugita

Sunao Sugita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A METHOD FOR DETECTING MICROORGANISMS
    Publication number: 20220235398
    Abstract: The present invention relates to a method for simultaneously detecting a plurality of pathogens from biologically-derived samples, and a kit for carrying out the method. Specifically, the present invention relates to a method for simultaneously detecting a plurality of pathogens that cause infectious uveitis, one of eye infections from samples such as anterior chamber fluid or vitreous by polymerase chain reaction (PCR), and a kit for carrying out the method.
    Type: Application
    Filed: March 4, 2022
    Publication date: July 28, 2022
    Inventors: Norio Shimizu, Hiroshi Takase, Manabu Mochizuki, Yasuhiro Tomaru, Satoko Nakano, Sunao Sugita, Masamitsu Shikata
  • METHOD AND A KIT FOR DETECTING PATHOGENS
    Publication number: 20210395840
    Abstract: This invention provides a simple analysis method by a PCR method that simultaneously performs, in a single container, separating nucleic acid of pathogens contained in a tissue fragment and preparing a PCR buffer solution, and a kit used for the analysis method. A method for detecting a pathogen includes: (1) obtaining a liquid specimen mixture by adding a tissue fragment containing a pathogen to a PCR buffer solution containing a proteolytic enzyme; (2) heating the liquid specimen mixture at a first temperature; (3) further heating at a second temperature; (4) performing PCR by adding a portion of the liquid mixture obtained in (3) above to a solid composition for PCR reaction containing DNA polymerase and one or more kinds of PCR primer pair; and (5) detecting a PCR product generated in (4) above.
    Type: Application
    Filed: January 27, 2021
    Publication date: December 23, 2021
    Applicants: SHIMADZU CORPORATION, National University Corporation Tokyo Medical and Dental University, Nihon Techno Service Co., Ltd., National University Corporation Oita University, RIKEN, Toho University
    Inventors: Masamitsu SHIKATA, Kenji NINOMIYA, Norio SHIMIZU, Hiroshi TAKASE, Manabu MOCHIZUKI, Yasuhiro TOMARU, Satoko NAKANO, Sunao SUGITA, Takashi SUZUKI
  • METHOD FOR DETECTING MICROORGANISMS
    Publication number: 20200385784
    Abstract: The present invention relates to a method for simultaneously detecting a plurality of pathogens from biologically-derived samples, and a kit for carrying out the method. Specifically, the present invention relates to a method for simultaneously detecting a plurality of pathogens that cause infectious uveitis, one of eye infections from samples such as anterior chamber fluid or vitreous by polymerase chain reaction (PCR), and a kit for carrying out the method.
    Type: Application
    Filed: June 4, 2020
    Publication date: December 10, 2020
    Inventors: Norio Shimizu, Hiroshi Takase, Manabu Mochizuki, Yasuhiro Tomaru, Satoko Nakano, Sunao Sugita, Masamitsu Shikata
  • Eye disease treatment agent, screening method therefor, and method for predicting rejection response associated with retinal pigment epithelial cell transplant
    Patent number: 10240201
    Abstract: The present invention provides an agent for treating ophthalmic diseases and a screening method for an agent for treating ophthalmic diseases and the like. The present invention also provides a method for predicting rejection associated with transplantation of retinal pigment epithelial cell to patients with ophthalmic diseases.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: March 26, 2019
    Assignee: Healios K.K.
    Inventors: Masayo Takahashi, Sunao Sugita
  • EYE DISEASE TREATMENT AGENT, SCREENING METHOD THEREFOR, AND METHOD FOR PREDICTING REJECTION RESPONSE ASSOCIATED WITH RETINAL PIGMENT EPITHELIAL CELL TRANSPLANT
    Publication number: 20170009298
    Abstract: The present invention provides an agent for treating ophthalmic diseases and a screening method for an agent for treating ophthalmic diseases and the like. The present invention also provides a method for predicting rejection associated with transplantation of retinal pigment epithelial cell to patients with ophthalmic diseases.
    Type: Application
    Filed: February 20, 2015
    Publication date: January 12, 2017
    Inventors: Masayo Takahashi, Sunao Sugita